Borderline personality disorder and the chronic headache patient: Review and management recommendations

Headache

Volumn 42, Issue 7, 2002, Pages 663-674

  Saper, Joel R ^a   Lake III, Alvin E ^a  

^a Michigan Head Pain and Neurological Institute   (United States)

Author keywords

Borderline personality disorder; Comorbidity; Contracts; Guidelines; Headache; Migraine

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FLUOXETINE; HALOPERIDOL; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NALOXONE; NALTREXONE; OLANZAPINE; OPIATE; OPIATE ANTAGONIST; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

BORDERLINE STATE; BRAIN DYSFUNCTION; BRAIN METABOLISM; BRAIN REGION; BRAIN SIZE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; COUNTER TRANSFERENCE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG USE; HEADACHE; HIPPOCAMPUS; HUMAN; INTERPERSONAL COMMUNICATION; MENTAL DISEASE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SUBSTANCE ABUSE;

BORDERLINE PERSONALITY DISORDER; CHRONIC DISEASE; HEADACHE; HUMANS; PREVALENCE; PSYCHOTHERAPY;

EID: 0036657018     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02156.x     Document Type: Review

References (61)

1. Comorbidity of migraine and major affective disorders
2. Migraine, quality of life, and depression: A population-based case-control study
3. Comorbidity of migraine and psychiatric disorders
4. Headache and psychiatric comorbidity: Clinical aspects and outcome in an 8-year follow-up study
5. Personality and personality disorders predict development and relapses of major depression
6. Differences between clinical and research practices in diagnosing borderline personality disorder
7. Psychoanalytic investigation and therapy in the borderline group of neuroses
8. Pain as a disease: Psychological investigation
9. The prevalence of cyclothymia in borderline personality disorder
10. Comorbidity of borderline personality disorder with other personality disorders in hospitalized adolescents and adults
11. Borderline personality disorder in adolescents: Ubiquitous or specific?
12. Borderline personality disorder
13. Borderline personality disorder: Course of illness
14. The Chestnut Lodge follow-up study: III. Long-term outcome of borderline personality disorder
15. The course of borderline personality disorder
16. Personality disorders in the general population: DSM-IV and ICD-10 defined prevalence as related to sociodemographic profile
17. Prevalences of personality disorders (DSM-III-R) in the community
18. The epidemiology of personality disorders: A 1990 update
19. Estimating the prevalence of borderline personality disorder in the community
20. Epidemiology of borderline personality disorder
21. Comorbidity of personality disorders and major depression in patients with somatoform pain disorders or medical illnesses with long-standing work disability
22. Borderline personality disorder and bipolar II disorder in private practice depressed outpatients
23. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder
24. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders
25. Personality disorders in adolescents with major depression, substance use disorders, and coexisting major depression and substance use disorders
26. The prevalence of migraine in borderline personality disorder
27. Prevalence and impact of migraine
28. Platelet serotonin, monoamine oxidase activity, and [3H] paroxetine binding related to impulsive suicide attempts and borderline personality disorder
29. Gender differences in personality disorders in psychiatrically hospitalized young adults
30. Dialectical behavior therapy for borderline personality disorder
31. Borderline personality disorder symptoms and severity of sexual abuse
32. Childhood maltreatment increases risk for personality disorders during early adulthood
33. Does childhood sexual abuse cause borderline personality disorder?
34. Brain glucose metabolism in borderline personality disorder
35. EEG theta activity and pain insensitivity in self-injurious borderline patients
36. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior
37. Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory
38. Pain perception in self-injurious patients with borderline personality disorder
39. Subtypes of self-injurious patients with borderline personality disorder
40. Pain and self-injury in borderline patients: Sensory decision theory, coping strategies, and locus of control
41. Self-injurious behavior and mood regulation in borderline patients
42. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: A open-label trial
43. Naltrexone as a treatment for repetitive self-injurious behaviour: An open-label trial
44. Naltrexone treatment of self-injurious thoughts and behaviors
45. The effects of exogenous analgesia in a patient with borderline personality disorder (BPD) and severe self-injurious behaviour
46. Combining pharmacotherapy with psychotherapy for substance abusers with borderline personality disorder: Strategies for enhancing compliance
47. Dialectical behavior therapy for treatment of borderline personality disorder: Implications for the treatment of substance abuse
48. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence
49. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients
50. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients
51. Focused time-limited inpatient treatment of borderline personality disorder
52. Haloperidol vs. phenelzine in continuation therapy of borderline disorder
53. Efficacy of phenelzine and haloperidol in borderline personality disorder
54. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder
55. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: A preliminary open trial of flupenthixol
56. Divalproex sodium as a treatment for borderline personality disorder